Ragosa Mark bought KNSA
November 12, 2025 · Form 4 insider transaction
Ragosa Mark bought 19,900 shares of Kiniksa Pharmaceuticals International, plc at $30.93 per share, a transaction worth $615.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,900
Price
$30.93
Total value
$615.5K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateNovember 12, 2025
Filing dateNovember 14, 2025
Shares owned after50,986
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.